| Product name: |
Senvelgo 15 mg/ml |
| Active substance: |
Velagliflozinum |
| Target tribe: |
|
| Drug form: |
Perorální roztok |
| Registration date: |
22. 11. 2023 |
| Registration number: |
EU/2/23/305/001 |
| Verdict holder: |
Boehringer Ingelheim Vetmedica, GmbH
Binger Strasse 173
Ingelheim am Rhein 55216
Phone: , Fax:
Email: |
| ATC vet. code: |
QA10BK - Velagliflozin |
| Pharmacotherapeutic group: |
Sodium-glucose co-transporter 2 (SGLT2) inhibitors |
| Narcotics: |
NO |
| Indication restriction: |
NO |
| Withdrawal period: |
|
| Procedure type: |
Centralised |
Table of active package codes| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
| 9910609 | 1 x 30 ml | lahvička | plast (HDPE) | - | - | Na předpis | | 9911015 | 1 x 12 ml | lahvička | plast (HDPE) | - | - | Na předpis |
| Package code | Size | Package type | Material | Identification code | EU number | Issue |
|---|
|
Authorisation & Approval 
